Intus Biosciences
Farmington, US · Founded 2014 · Connecticut LLC · 1 known investors
Intus Bio develops microbiome analysis technology combining patented science, long-read sequencing, and AI to generate high-resolution microbiome data for healthcare applications. The company serves healthcare organizations, pharmaceutical developers, and clinical researchers seeking novel biomarker discovery and patient diagnostics.
Founders & leadership
PD
Paul DenslowinExecutive Officer, Director
TP
Thomas P JarvieExecutive Officer, Director
MD
Mark D. DriscollExecutive Officer, Director
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$1.1MraisedMay 2025 · 8 investors · BiotechnologyRule 506(b)
▶$1.1MraisedMay 2025 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Donna GalluzzoDirector
- Paul DenslowExecutive Officer, Director
- Frank J. MarcoDirector
- Alan MendelsonDirector
- Daniel WagnerDirector
- Mark DriscollDirector
- Offering amount
- $3M
- Amount sold
- $1.1M
- First sale
- May 2025
- Incorporated
- Limited Liability Company, Connecticut
- Federal exemptions
- 06b
▶$2MraisedJul 2024 · 25 investors · BiotechnologyRule 506(b)
▶$2MraisedJul 2024 · 25 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Paul DenslowExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $2M
- First sale
- Jun 2024
- Incorporated
- Limited Liability Company, Connecticut
- Federal exemptions
- 06b
▶$1.1MraisedNov 2022 · 1 investors · BiotechnologyRule 506(b)
▶$1.1MraisedNov 2022 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Thomas JarvieExecutive Officer, Director
- Paul DenslowExecutive Officer, Director
- Alan MendelsonDirector
- Matt WatsonDirector
- Frank J. MarcoDirector
- Offering amount
- $3.5M
- Amount sold
- $1.1M
- First sale
- Nov 2022
- Incorporated
- Limited Liability Company, Connecticut
- Federal exemptions
- 06b
▶$800KraisedJul 2022 · 1 investors · BiotechnologyRule 506(b)
▶$800KraisedJul 2022 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- William McKenzieDirector
- H. Mark LunenburgDirector
- David WurzerDirector
- Paul DenslowExecutive Officer, Director
- Alan MendelsonDirector
- Thomas JarvieExecutive Officer, Director
- Frank J. MarcoDirector
- Offering amount
- $1.5M
- Amount sold
- $800K
- First sale
- Jun 2022
- Incorporated
- Limited Liability Company, Connecticut
- Federal exemptions
- 06b
▶$250KraisedFeb 2022 · 4 investors · BiotechnologyRule 506(b)
▶$250KraisedFeb 2022 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- William McKenzieDirector
- H. Mark LunenburgDirector
- David WurzerDirector
- Thomas JarvieExecutive Officer, Director
- Paul DenslowDirector
- Frank MarcoDirector
- Offering amount
- $250K
- Amount sold
- $250K
- First sale
- Jan 2022
- Incorporated
- Limited Liability Company, Connecticut
- Federal exemptions
- 06b
▶$330KraisedJan 2021 · 5 investors · BiotechnologyRule 506(b)
▶$330KraisedJan 2021 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Thomas JarvieExecutive Officer, Director
- William McKenzieDirector
- Frank MarcoDirector
- Patrick O'NeillDirector
- H. Mark LunenburgDirector
- Offering amount
- $1M
- Amount sold
- $330K
- First sale
- Dec 2020
- Incorporated
- Limited Liability Company, Connecticut
- Federal exemptions
- 06b
▶$2.2MraisedMay 2020 · 16 investors · BiotechnologyRule 506(b)
▶$2.2MraisedMay 2020 · 16 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Thomas JarvieExecutive Officer, Director
- William McKenzieDirector
- Patrick O'NeillDirector
- Frank MarcoDirector
- H. Mark LunenburgDirector
- Offering amount
- $2.2M
- Amount sold
- $2.2M
- First sale
- May 2019
- Incorporated
- Limited Liability Company, Connecticut
- Federal exemptions
- 06b
▶$1.8MraisedDec 2017 · 10 investors · BiotechnologyRule 506(b)
▶$1.8MraisedDec 2017 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Frank J. MarcoDirector
- Mark D. DriscollExecutive Officer, Director
- Patrick O'NeillDirector
- Thomas P. JarvieExecutive Officer, Director
- Offering amount
- $1.9M
- Amount sold
- $1.8M
- First sale
- Dec 2017
- Incorporated
- Limited Liability Company, Connecticut, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.